Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREMI: First-line Preventive Migraine Treatment
NCT06499116Phase 4Not yet recruiting
- Sponsor
- IDIAPJGol
- Start
- Oct 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of topiramate, flunarizine, amitriptyline in migraine, sponsored by IDIAPJGol. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
topiramateflunarizineamitriptyline
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06499116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06499116.